CIPO Patents = 2

EPO Patents = 2

Trademarks = 2

Forward Citations = 8

Loading Chart...

8 inventors (with patents filed for the assignee):

Andrés Gagete Mateos (6 out of 6 patents)

Julio Castro (4 out of 4 patents)

Peter J Machin (4 out of 23 patents)

4. Christopher Loren Vandeusen (4 out of 8 patents)

5. Julio Castro Palomino (3 out of 5 patents)

6. Luc Marti Clauzel (3 out of 4 patents)

7. Damiá Tormo Carulla (3 out of 4 patents)

8. Andrés Gagete Mateos (1 out of 2 patents)

9. Andres Gagete Mateos (0 patent)

10. Damia Tormo Carulla (0 patent)

7 patents: Sort by Forward Citations

1. 12319675 - Chromene derivatives as inhibitors of TCR-Nck interaction (2025-06-03),

2. 11807633 - Chromene derivatives as inhibitors of TCR-Nck interaction (2023-11-07),

3. 11505526 - Aryl-piperidine derivatives (2022-11-22),

4. 11434239 - Aza-dihydro-acridone derivatives (2022-09-06),

5. 11008310 - Chromene derivatives as inhibitors of TCR-Nck interaction (2021-05-18),

6. 10696663 - Chromene derivatives as inhibitors of TCR-NCK interaction (2020-06-30),

7. 10106518 - Chromene derivatives as inhibitors of TCR-Nck interaction (2018-10-23),

Company Overview

Artax Biopharma Inc. is a biotechnology company dedicated to developing innovative therapies for cancer and other serious diseases. With a focus on precision medicine and targeted drug delivery, Artax is at the forefront of personalized medicine. Our team of experienced scientists and researchers are committed to advancing the field of biopharmaceuticals and improving patient outcomes. Visit our website to learn more about our pipeline of novel therapies and collaborations.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

7 Patents

#295 in Cambridge, MA

#2,306 in Massachusetts

#39,929 in US

Cambridge, MA, United States of America

Artax Biopharma Inc.

Forward Citations = 8

8 inventors:

Andrés Gagete Mateos (6 out of 6 patents)

Julio Castro (4 out of 4 patents)

Peter J Machin (4 out of 23 patents)

4. Christopher Loren Vandeusen (4 out of 8 patents)

5. Julio Castro Palomino (3 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Artax Biopharma Inc.. Retrieved from https://idiyas.com/company/artax-biopharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]